Anúncio
Anúncio

BCTX

BCTX logo

Briacell Therapeutics Corp. Common Shares

7.25
USD
Patrocinado
-0.04
-0.48%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

7.28

+0.03
+0.41%

Relatórios de Lucros BCTX

Rácio de surpresa positiva

BCTX separação 7 de 15 últimas estimativas.

47%

Próximo Relatório

Data do Próximo Relatório
10 de mar. de 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$4.88
Mudanças implicadas de Q1 26 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q2 25 (Revenue/ EPS)
--
/
-79.06%

Briacell Therapeutics Corp. Common Shares earnings per share and revenue

On 15 de dez. de 2025, BCTX reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -3.31 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 2.12 milhão, with a --% difference.
Looking ahead to Q2 26, 2 analistas forecast an EPS of -4.88 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q1 2026, Briacell Therapeutics Corp. Common Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for 10 de mar. de 2026.
Based on 2 analistas, Briacell Therapeutics Corp. Common Shares is expected to report EPS of -$4.88 and revenue of -- for Q2 2026.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio